Literature DB >> 16388321

Diagnostic value of tumor markers for differentiating malignant and benign pleural effusions of Iranian patients.

Sied Mohammad Ali Ghayumi1, Samrad Mehrabi, Mehrnossh Doroudchi, Abbas Ghaderi.   

Abstract

In order to evaluate the diagnostic yield of tumor markers in differentiating malignant and benign pleural effusions, we carried out a prospective study in a group of Iranian people. Pleural and serum levels of carcinoembryonic antigen (CEA), carbohydrate antigen 15-3 (CA 15-3), neuron-specific enolase (NSE) and cancer antigen 125 (CA 125) were assayed prospectively in patients with pleural effusion (40 malignant and 37 benign). The highest sensitivity was obtained with a combination of CA 15-3 in serum, and CA 15-3 and CEA in pleural fluid (80%), also with combination of CA 15-3 in serum, and CA 15-3, NSE and CEA in pleural fluid (80%). The highest specificity was obtained with combination of CA 15-3 in serum, and CA 15-3 and NSE in pleural fluid (100%), and also with combination of CA 15-3 in serum, and CA15-3, NSE and CEA in pleural fluid (100%).

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16388321     DOI: 10.1007/BF02893857

Source DB:  PubMed          Journal:  Pathol Oncol Res        ISSN: 1219-4956            Impact factor:   3.201


  24 in total

1.  BTS guidelines for the investigation of a unilateral pleural effusion in adults.

Authors:  N A Maskell; R J A Butland
Journal:  Thorax       Date:  2003-05       Impact factor: 9.139

2.  Carcinomatous involvement of the pleura: an analysis of 96 patients.

Authors:  B Chernow; S A Sahn
Journal:  Am J Med       Date:  1977-11       Impact factor: 4.965

3.  Diagnostic value of CEA, CA 15-3, CA 19-9, CYFRA 21-1, NSE and TSA assay in pleural effusions.

Authors:  F Alataş; O Alataş; M Metintaş; O Colak; E Harmanci; S Demir
Journal:  Lung Cancer       Date:  2001-01       Impact factor: 5.705

4.  [The behavior of carcinoembryonic antigen in pleural empyema].

Authors:  E García-Pachón; I Padilla Navas; M Querol; J Custardoy
Journal:  Med Clin (Barc)       Date:  1993-07-03       Impact factor: 1.725

5.  Diagnostic value of CA 72-4, carcinoembryonic antigen, CA 15-3, and CA 19-9 assay in pleural fluid. A study of 207 patients.

Authors:  V Villena; A López-Encuentra; J Echave-Sustaeta; P Martín-Escribano; B Ortuño-de-Solo; J Estenoz-Alfaro
Journal:  Cancer       Date:  1996-08-15       Impact factor: 6.860

6.  Comparison of needle biopsy with cytologic analysis for the evaluation of pleural effusion: analysis of 414 cases.

Authors:  U B Prakash; H M Reiman
Journal:  Mayo Clin Proc       Date:  1985-03       Impact factor: 7.616

7.  CEA, CA 15-3 and CYFRA 21-1 in serum and pleural fluid of patients with pleural effusions.

Authors:  S Romero; C Fernández; J M Arriero; A Espasa; A Candela; C Martín; J Sánchez-Payá
Journal:  Eur Respir J       Date:  1996-01       Impact factor: 16.671

8.  The role of concurrent determinations of pleural fluid and tissue carcinoembryonic antigen in the distinction of malignant mesothelioma from metastatic pleural malignancies.

Authors:  B Faravelli; M Nosenzo; A Razzetti; D Barone; E D'Amore; R Bandelloni; C Gambini; P G Betta; A Donna
Journal:  Eur J Cancer Clin Oncol       Date:  1985-09

Review 9.  Diagnosis and management of malignant pleural effusions.

Authors:  K N Fenton; J D Richardson
Journal:  Am J Surg       Date:  1995-07       Impact factor: 2.565

10.  The implication of elevated carcinoembryonic antigen level in pleural fluid of patients with non-malignant pleural effusion.

Authors:  Jeong-Seon Ryu; Hun-Jae Lee; Jae-Hwa Cho; Hye-Seung Han; Hong-Lyeol Lee
Journal:  Respirology       Date:  2003-12       Impact factor: 6.424

View more
  11 in total

1.  Lectin microarrays differentiate carcinoma cells from reactive mesothelial cells in pleural effusions.

Authors:  Yu-Qing Shi; Qun He; Yu-Jie Zhao; En-Hua Wang; Guang-Ping Wu
Journal:  Cytotechnology       Date:  2012-08-09       Impact factor: 2.058

2.  Diagnostic value of carbohydrate antigens in supernatants and sediments of pleural effusions.

Authors:  Daniela Terracciano; Claudia Mazzarella; Marcellino Cicalese; Sonia Galzerano; Gianfranco Apostolico; Angelina DI Carlo; Angela Mariano; Ciriaco Cecere; Vincenzo Macchia
Journal:  Oncol Lett       Date:  2010-05-01       Impact factor: 2.967

3.  Management of occult malignant pleural disease firstly detected at thoracotomy for non-small cell lung cancer patients.

Authors:  Shaolei Li; Shanyuan Zhang; Miao Huang; Yuanyuan Ma; Yue Yang
Journal:  J Thorac Dis       Date:  2017-10       Impact factor: 2.895

4.  Transcription expression and clinical significance of dishevelled-3 mRNA and δ-catenin mRNA in pleural effusions from patients with lung cancer.

Authors:  Xiao-Yan Li; Shu-Li Liu; Na Cha; Yu-Jie Zhao; Shao-Cheng Wang; Wei-Nan Li; En-Hua Wang; Guang-Ping Wu
Journal:  Clin Dev Immunol       Date:  2012-02-23

5.  Clinical diagnostic utility of CA 15-3 for the diagnosis of malignant pleural effusion: A meta-analysis.

Authors:  Qiang Wu; Min Li; Shu Zhang; Lu Chen; Xingting Gu; Feng Xu
Journal:  Exp Ther Med       Date:  2014-10-30       Impact factor: 2.447

6.  Diagnostic Value of Neuron-Specific Enolase (NSE) and Cancer Antigen 15-3 (CA 15-3) in the Diagnosis of Pleural Effusions

Authors:  Mohammad Ali Saba; Toraj Valeh; Hasan Ehteram; Hamed Haddad Kashani; Mahdiyeh Ghazi Zahedi
Journal:  Asian Pac J Cancer Prev       Date:  2017-01-01

7.  Diagnostic Utility of Combined CEA, CA15-3 and CA125 Biomarkers and Cytomorphology in Suspicious and Malignant Serosal Fluid.

Authors:  Zahra Rahemi; Abdolreza Javadi; Behrang Kazeminejad; Abdolali Ebrahimi; Houman Vosough; Afsoon Taghavi; Shahriar Dabiri
Journal:  Iran J Pathol       Date:  2021-05-09

8.  The utility of tumor markers CA 125, CA 15-3, and CA 19-9 in assessing the response to therapy in pulmonary and pleural tuberculosis.

Authors:  Canturk Tascı; Sevket Ozkaya; Bikemgul Ozkara; Ergun Tozkoparan; Metin Ozkan; Nuri Karadurmus; Muhittin Serdar; Arzu Balkan; Hayati Bilgic
Journal:  Onco Targets Ther       Date:  2012-11-22       Impact factor: 4.147

9.  Is neuron-specific enolase useful for diagnosing malignant pleural effusions? evidence from a validation study and meta-analysis.

Authors:  Jing Zhu; Mei Feng; Liqun Liang; Ni Zeng; Chun Wan; Ting Yang; Yongchun Shen; Fuqiang Wen
Journal:  BMC Cancer       Date:  2017-08-30       Impact factor: 4.430

10.  Diagnostic value of tumour markers in pleural effusions.

Authors:  Darian Volarić; Veljko Flego; Gordana Žauhar; Ljiljana Bulat-Kardum
Journal:  Biochem Med (Zagreb)       Date:  2018-01-10       Impact factor: 2.313

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.